STELLA PHARMA
NEWS

December 25th, 2024

Stella Pharma Concludes MOU on Boron Neutron Capture Therapy System with Fujita Health University, Atransen Pharma, SHI, and Fujita

Stella Pharma Corporation has concluded a Memorandum of Understanding (MOU) to ……

READ MORE

December 10th, 2024

Observation Period Completed for Primary Endpoint – Phase II Clinical Trial in Patients with Angiosarcoma

We are pleased to announce the completion of the 90-day observation period for ……

READ MORE

December 6th, 2024

Paper published: Poly(vinyl alcohol) Potentiating an Inert D-Amino Acid-Based Drug for Boron Neutron Capture Therapy

The paper titled “Poly(vinyl alcohol) potentiating an inert D-amino acid-based ……

READ MORE

November 20th, 2024

Paper published: Research on Combination of Proton Beam Therapy and Boron Nuclear Capture Reaction

The Paper titled “Increased cell killing effect in neutron capture enhanced pro……

READ MORE